Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
5.82
+0.01 (0.17%)
Apr 8, 2026, 3:46 PM HKT
Charmacy Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 53.28 | 51.34 | 90.47 | 23.15 | Upgrade
|
| Depreciation & Amortization | - | 29.75 | 26.47 | 30.68 | 32.03 | Upgrade
|
| Other Amortization | - | 6.27 | 2.95 | 2.89 | 1.73 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.31 | -0.05 | -65.84 | -0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.36 | -0.01 | - | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 0.1 | - | -0 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.07 | 0.8 | 2.48 | -0.29 | Upgrade
|
| Other Operating Activities | - | 38.14 | 41.16 | 36.31 | 41.71 | Upgrade
|
| Change in Accounts Receivable | - | -409.63 | -98.17 | -222.47 | -54.81 | Upgrade
|
| Change in Inventory | - | 116.04 | -193.35 | -77.74 | 75.75 | Upgrade
|
| Change in Accounts Payable | - | 272.54 | 72.25 | 245.77 | -139.9 | Upgrade
|
| Operating Cash Flow | - | 106.04 | -96.54 | 44.05 | -19.54 | Upgrade
|
| Capital Expenditures | - | -15.73 | -40.85 | -8.59 | -25.04 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.08 | 80.19 | 80.35 | 0.64 | Upgrade
|
| Other Investing Activities | - | - | - | - | 0 | Upgrade
|
| Investing Cash Flow | - | -15.64 | 39.34 | 71.76 | -24.4 | Upgrade
|
| Short-Term Debt Issued | - | 3,688 | 2,492 | 2,852 | 1,807 | Upgrade
|
| Long-Term Debt Issued | - | 1,266 | 836.6 | 2.26 | 974.03 | Upgrade
|
| Total Debt Issued | - | 4,955 | 3,329 | 2,855 | 2,781 | Upgrade
|
| Short-Term Debt Repaid | - | -3,883 | -2,388 | -3,017 | -1,830 | Upgrade
|
| Long-Term Debt Repaid | - | -1,038 | -767.41 | -3.58 | -824.11 | Upgrade
|
| Total Debt Repaid | - | -4,921 | -3,156 | -3,021 | -2,654 | Upgrade
|
| Net Debt Issued (Repaid) | - | 33.98 | 172.72 | -166.48 | 126.33 | Upgrade
|
| Common Dividends Paid | - | -64.2 | -75.5 | -28.44 | -52.49 | Upgrade
|
| Other Financing Activities | - | -1.31 | 4.04 | 3.71 | 0.56 | Upgrade
|
| Financing Cash Flow | - | -31.54 | 101.26 | -191.21 | 74.4 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.01 | 0.01 | 0.03 | - | Upgrade
|
| Net Cash Flow | - | 58.87 | 44.07 | -75.37 | 30.46 | Upgrade
|
| Free Cash Flow | - | 90.31 | -137.39 | 35.46 | -44.58 | Upgrade
|
| Free Cash Flow Margin | - | 2.04% | -3.12% | 0.85% | -1.18% | Upgrade
|
| Free Cash Flow Per Share | - | 0.84 | -1.27 | 0.33 | -0.41 | Upgrade
|
| Cash Income Tax Paid | - | 52.98 | 58.86 | 36.02 | 37.42 | Upgrade
|
| Levered Free Cash Flow | - | -69.75 | 10.27 | -145.91 | -28.06 | Upgrade
|
| Unlevered Free Cash Flow | - | -30.71 | 36.48 | -123.99 | -2.12 | Upgrade
|
| Change in Working Capital | - | -21.53 | -219.31 | -52.94 | -117.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.